Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jul;129(7):375-82.
doi: 10.1007/s00432-003-0459-1. Epub 2003 Jul 15.

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

Pia Wülfing  1 , Raihanatou Diallo, Christine Müller, Christian Wülfing, Christopher Poremba, Achim Heinecke, Achim Rody, Robert R Greb, Werner Böcker, Ludwig Kiesel
Affiliations

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

Pia Wülfing et al. J Cancer Res Clin Oncol. 2003 Jul.

Abstract

Purpose: The objective of this study was to evaluate breast carcinomas for the expression of cyclooxygenase-2 (Cox-2) using a tissue microarray (TMA) and to determine its clinical and prognostic relevance.

Methods: We analyzed Cox-2 expression in 600 samples from 200 breast carcinomas immunohistochemically performing TMA technology and semiquantitative analysis. Results were correlated with various clinicopathological variables and follow-up data. Expression of estrogen receptor, progesterone receptor, Ki-67, and Her-2/neu-oncogene was analyzed and correlated with Cox-2 status.

Results: We observed a moderate or strong cytoplasmic staining for Cox-2 in 78 (40.6%) of breast carcinomas. Increased Cox-2 expression corresponded to higher pT stage ( P=0.038), amplification of Her-2/neu ( P=0.032), lymphovascular invasion ( P=0.006), a high MIB-1 labeling index (LI) ( P<0.001), and histological grading ( P=0.013). We also observed an inverse relationship between strong Cox-2 expression and estrogen and progesterone receptor content of tumors ( P=0.037 and P=0.010). However, we could not demonstrate a significant association between Cox-2 staining and overall survival or disease free survival time.

Conclusions: These results suggest that Cox-2 expression is significantly associated with less differentiated and more aggressive breast carcinomas and might therefore be a useful prognostic indicator as well as a target for therapy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Tissue microarray block
Fig. 2A-F.
Fig. 2A-F.
Breast cancer samples of TMA with immunohistochemical expression of A Cox-2, B estrogen receptor, C progesterone receptor, D MIB-1), E Her-2/neu (magnification ×100); F in situ hybridization for Her-2/neu
Fig. 3A-H.
Fig. 3A-H.
Association between Cox-2 and clinicopathological features in patients with primary breast cancer (n = 178). A Cox-2 expression and pT-stage; P=0.002; B Cox-2 expression and lymphovascular invasion; P=0.003; C Cox-2 expression and MIB-1 labeling index (LI ≤20% vs LI >20%); P=0.010; D Cox-2 expression and Her-2/neu amplification; NS; P=0.168; E Cox-2 expression and histological differentiation (grading); P=0.038; F Cox-2 expression and expression of estrogen receptor; NS (P=0.080); G Cox-2 expression and expression of progesterone receptor; P=0.023; H Cox-2 expression and pN status; P=0.041
Fig 4A,B.
Fig 4A,B.
Survival distribution functions (OS and DFST) in patients with primary breast cancer (n = 178). A Overall survival (OS) in patients with Cox-2-negative (n = 94) vs patients with Cox-2-positive (n = 66) tumors; NS (P=0.227); B Disease-free survival time (DFST) in patients with Cox-2-negative (n = 82) vs patients with Cox-2-positive (n = 57) tumors; NS (P=0.525)
See this image and copyright information in PMC

References

    1. Alshafie GA, Abou-Issa HM, Seibert K, Harris RE (2000) Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep 7:1377–1381 - PubMed
    1. Altman DG (1995) Chi square test for trend. In: Practical statistics for medical research. Chapman & Hall, London, pp 261–265
    1. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS (2001) Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 7:1410–1418 - PubMed
    1. Bandyopadhyay GK, Imagawa W, Wallace D, Nandi S (1987) Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J Biol Chem 262:2750–2756 - PubMed
    1. Bankfalvi A, Navabi H, Bier B, Bocker W, Jasani B, Schmid KW (1994) Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174:223–228 - PubMed